Trace elements play a pivotal role in normal development, health, and protection of human body, as other essential nutrients do, and their insufficiency may result in a variety of diseases.\[[@ref1]\] Among the trace elements, selenium (Se) in trace amounts is indispensable for the maintenance of good health.\[[@ref2][@ref3]\] It is an essential component of the enzyme glutathione peroxidase that prevents cellular damage from free radicals.\[[@ref4]\] Selenium also plays a crucial role in the detoxification of liver enzymes, enhancing immune function as well as providing antioxidant defiance. Selenium is found in minute amounts in foods\[[@ref5]\] with the richest source being found in meat, fish, whole grains, and dairy products. The recommended dietary allowances (RDA) of selenium in the USA are 55 *μ*g/day for women and 70 *μ*g/day for men.

Epidemiologic studies have shown that low grain selenium content is associated with a high regional incidence of hepatitis B viral infections.\[[@ref6]\] Selenium deficiency has been involved in the pathogenesis of a number of clinical findings in chronic liver diseases. Hepatitis B and C are viral diseases resulting from DNA, and RNA type virus involves progressive immune dysfunction. The protective role of selenium against hepatitis was reported first in 1997. Different studies have shown lower concentration of selenium in the serum and erythrocytes of hepatitis B and C patients\[[@ref7][@ref8]\] and hepatitis B and C patients are at a high risk for poor response to bacterial and viral infections. Selenium deficiency reduces immune functions, increases inflammatory effects, resulting in impairment of the activities of leukocytes, neutrophil and macrophages.\[[@ref9]--[@ref11]\]

Hepatitis C viral infection is linked with low blood levels of antioxidants, including selenium\[[@ref12]--[@ref14]\] and elevated level of oxidative stress.\[[@ref15]--[@ref17]\] Four-year animal studies showed that nutritional supplement of selenium decreased the hepatitis B virus (HBV) infection by 77.2%.\[[@ref18]\] The deficiency of selenium is common in patients with hepatitis due to poor appetite during infection, decrease in intake and absorption, decreased bioavailability, and increased losses because of malabsorption. The present study was designed with an objective to find out serum selenium concentrations in patients suffering from HBV and hepatitis C virus (HCV) in our setup and to suggest any recommendation if required, of selenium supplementation by health care planners, gastroenterologists, and hepatologists.

PATIENTS AND METHODS {#sec1-1}
====================

Selection of hepatitis B and C patients {#sec2-1}
---------------------------------------

A total of 150 Pakistani individuals of both sexes aged between 18 and 60 years with hepatitis B and C were selected for the study. The randomly selected study group comprised 107 patients with HCV (71 male and 36 females) and 43 patients with HBV (38 male and 5 females). Samples were collected from Pakistan Institute of Medical Sciences (PIMS), Polyclinic Hospital, CDA Hospital, and Markaz Labs, located in Islamabad, the capital city of Pakistan. All the patients were examined by the consultant gastroenterologists and their entire medical history and physical examination were documented. Exclusion criteria were patients with heart diseases, obese persons, patients with diabetes mellitus, and those who had already been on total parenteral nutrition.

### Main outcome measures {#sec3-1}

All subjects included in the study were screened for HBV and HCV by rapid methodth and confirmed by ELISA technique.

Selection of healthy subjects (controls) {#sec2-2}
----------------------------------------

A total of 26 apparently healthy subjects of both sexes, aged between 18 and 60 years residing in the same area were selected for this study. The subjects were all apparently healthy and were selected with no history of smoking, hypertension, and any acute or chronic liver pathology.

Sample collection and preservation {#sec2-3}
----------------------------------

After taking informed consent and ethical approval from ethical committee of the institution, about 5 cc blood was taken from the antecubital vein of patients and healthy subjects. The samples were left undisturbed for 1 h to clot and were then centrifuged at 5000 rpm for 15 min. The collected sera were stored in Eppendorff vials at --20°C until further analysis.

Sample preparation and digestion {#sec2-4}
--------------------------------

Before analysis all the glassware was washed in dilute nitric acid (HNO~3~ 10%) and rinsed carefully with distilled water in order to keep out the risk of contamination. All the solutions and standard were prepared in double distilled water. A standard solution (1000 *μ*g/L) of selenium was obtained from Merck, Germany. Working standards were prepared by appropriate dilution of the stock solution with (0.5% v/v) HNO~3~. HNO~3~ (65%), hydrochloric acid (HCl 37%), and sodium hydroxide (NaOH) were purchased from Merck, Germany, and perchloric acid (HClO~4~ 70%) and sodium borohydride (NaBH~4~) were from BDH, UK origin.

The sodium borbhydride pellets were dissolved in a 1% sodium hydroxide solution to give 3% NaBH~4~. Three milliliters of 3% super pure HCl was used for hydride generator with continuous flow generation system HS-55. A sample of the serum (1 ml) was transferred to a Teflon beaker for mineralization, then 3 ml of HNO~3~/HCLO~4~ (1:1 v/v) was added. The temperature of the sample was then brought gradually to boiling point on a hot plate, until fumes of HClO~4~ appeared. Samples were then heated according to the following temperature/time scheme: 175°C/60 min, 200°C/60 min and finally 250°C/60 min. The mixture was then heated according to the following (temperature/ time) scheme: 175°C for 60 min, 200°C for 60 min, and finally 250°C for 60 min. The mixture was then left to cool down to room temperature. Then 10 ml of (6N) HCl was added and the sample was heated again on hot plate to 170°C for 30 min to reduce Se (VI) to Se (IV).

Sample analysis {#sec2-5}
---------------

The digested serum samples were analyzed for selenium by using atomic absorption spectrophotometer equipped with hydride generation system, model Analytic Jena (Vario III). Analytical calibration was accomplished with aqueous standards in 0.5% (v/v) HNO~3~. Fresh calibrations were made each time before analysis.

ADI calculation {#sec2-6}
---------------

ADI is the measure of the amount of a specific substance usually a food additive, or a residue of veterinary drug or pesticide in food or drinking water that can be ingested orally on a daily basis over a life time without an appreciable health risk and is calculated by using the following formula of Navarro *et al*.\[[@ref19]\]
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Statistical analysis {#sec2-7}
--------------------

All statistical analysis including the calculation of mean±SD, range and variance were calculated. Level of significance was calculated using *t* test. *P* values \>0.05 were considered nonsignificant.

RESULTS {#sec1-2}
=======

The results presented in [Table 1](#T1){ref-type="table"} show the age and gender wise distribution of mean serum selenium concentration (mg/L) along with ADI among male and female patients suffering from hepatitis C and B in comparison with healthy control. The mean serum selenium concentration in male HCV patients was 101.60±0.55 (mg/L), whereas the mean ADI calculated for HCV patients was 67.77±61.75 mg. The mean serum selenium concentration in female HCV patients was 77.43±0.47 (mg/L), while, the mean ADI was 51.62±36.78 mg, respectively.
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Age and gender wise distribution of selenium concentration and ADI among male and female patients affected due to hepatitis B were 107.58±0.44 *μ*g/L. ADI calculated for HBV male patients was 71.73±59.28 mg. However, the serum selenium concentration and ADI of HBV female patients were 137.8±0.36 *μ*g/L and 91.86±92.12 *μ*g, respectively. The mean serum selenium concentration and ADI of healthy male were 214.37±164.03*μ*g/L and 134.51±62.31 *μ*g. The mean serum selenium concentration and ADI of healthy female were 199±103.97 *μ*g/L and 132.67±69.31 *μ*g, respectively.

Analysis of *t* test showed a significant difference between two groups regarding serum selenium concentration (*P*\<0.001), however, no significant differences were observed between age and ADI among HBV and HCV patients.

DISCUSSION {#sec1-3}
==========

Trace elements play an important role in one form or another form as a protective and therapeutic agent in combating disease. Disproportion in this trace element has been linked with a diversity of diseases. Selenium is an essential trace element for various animal species, including human beings.\[[@ref16]\] The liver is known for its vital role in the metabolism and homeostasis of selenium in the human system,\[[@ref17][@ref18]\] as most of the selenoproteins are synthesized and secreted by the liver.\[[@ref20][@ref21]\]

The selenium concentration in healthy individuals reported in the present study were in the range of 30--580 mg/L, which were 90--470 mg/L in females and 30--580 mg/L among males. These results showed a higher concentration of selenium in males. By means of 1.51 (median correlation factor) as introduced by Navarro *et al*, to calculate the intake of nutrients on a daily basis, the daily intake of selenium in the present study was in the range of 60--313 mg for women in the age group of 18--46 years and 27--387 mg for men having age group in the range of 18-46 years.\[[@ref19]\] The ADI was also decreased from 88.82 to 34.07 mg with increase in age. However, among the age group of 18--30 years, the mean ADI was just sufficient to the value recommended by American RDA (70 mg). Patients of the age group 31--60 years showed less ADI value than the recommended one. Aging occurs as a consequence of low antioxidants, rise in free radicals, as well as progressive defects in defense against free radicals damage. Free radicals are responsible for lipid peroxidation in cell membrane, which leak out lysosomal hydrolases causing muscle dystrophy, as a consequence muscles become weak. With growing age, the oxidative stress increases which damages DNA proteins and lipids of the skeletal muscles.\[[@ref22][@ref23]\]

Serum selenium concentration decreases as the disease progresses from acute to chronic stage.\[[@ref24][@ref25]\] In this context, other authors linked reduced serum selenium concentration with progression of severe cirrhotic conditions. Similarly, we also found low serum selenium concentration in patients with hepatitis B and C, which was 101.60±0.55 and 77.43±0.47 *μ*g/L in male and female patients with hepatitis C, whereas in hepatitis B patients the concentration was 107.58±0.44 and 137.8±0.36 *μ*g/L among male and female patients, respectively, showing significant (*P*\<0.001) differences between HCV and HBV patients.

Al-Bader *et al*.\[[@ref26]\] observed a significant decrease of serum selenium concentration accompanied by liver cirrhosis in rats when they were given thioacetamide, and the changes were reversed when selenium supplementation was introduced. On the other hand, Buljevac *et al*.\[[@ref17]\] did not find significant differences in serum selenium concentrations in patients with liver cirrhosis and in those with liver cirrhosis and coexistent hepatocellular carcinoma, whereas Kalkan *et al*\[[@ref27]\] also identified selenium deficiency in patients with viral hepatitis.

The results of our study are tabulated in [Table 2](#T2){ref-type="table"}. The concentration of selenium (*μ*g/L) reported in the European countries, such as Finland, New Zealand, Poland, Brazil, W Germany, Sweden, Germany (Dresden), Switzerland, England, and Canada were 41.7l, 47.20, 72.3±14.1, 73.20, 81.10, 85.00, 86.0±13.4, and 96.0±13.3 (men), 87.9±14.4 (women), 115.70, 158.30, respectively, whereas the concentration of selenium (*μ*g/L) reported in the serum of some Asian countries, such as Japan, Iran, and Saudi Arabia were 97.60, 100.3, 102.5, respectively,\[[@ref28]--[@ref33]\] whereas the concentration of selenium (*μ*g/L) reported in the present study in Pakistani males was (214.37±164.03 *μ*g/L) and in females was (199±103 mg/L), which is comparatively higher than the levels calculated for other countries, indicating that the normal Pakistani diet has an adequate content of selenium for both genders.
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Globally, the dietary intake of selenium varies extensively, as selenium concentrations in plant-based foods reflect the concentration of selenium in the soil where the plants were grown. The current dietary requirements for selenium by the Food and Nutrition Board of the Institute of Medicine are based to some extent upon maintenance of optimal levels of selenoproteins in blood, particularly plasma glutathione peroxidase.\[[@ref34]\] The selenium requirement for prevention of chronic disease has not yet been definitively determined.\[[@ref35]\] but however, for the optimal activity of glutathione peroxidase, the minimum values of serum selenium should be 100 *μ*g/L or greater.\[[@ref36]\]

Selenium is a micronutrient and its margin of usefulness and harmfulness is quite narrow. The observations in this study showed the importance of selenium measurement in hepatitis B and C patients and to identify the possible deficiency of selenium in these individuals. It is concluded that the serum selenium concentrations were low in patients suffering from hepatitis B and C as compared with healthy group. Intake of foods, such as sea foods, meat, and whole grains, which are generally good sources of selenium, may decrease the risk of hepatic damage in population predisposed to viral infections. As a consequence, we append, a diet poor in selenium sources, such as fruits and vegetables can increase hepatic damage in those who are predisposed to liver damage. Based on the findings of this study, it is suggested that patients suffering from hepatitis B and C should first undergo selenium deficiency test, then administration of selenium may be proposed if required, for such patients affected due to hepatitis B and C.

CONCLUSION {#sec1-4}
==========

The findings of this study showed that serum selenium concentration of hepatitis B and C patients is less than serum selenium concentration of healthy individuals. Based on these findings, it is suggested that further interventional studies may be needed to analyze selenium concentration before and after supplementation and then recommendation may be given in such patients in order to optimize nutritional support and to get better treatment response.
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